The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
DNAX Accessory Molecule-1 Mediated Recognition of Freshly Isolated Ovarian Carcinoma by Resting Natural Killer Cells
Open accessPublished version of a preprint
Abstract
Although natural killer (NK) cells are well known for their ability to kill tumors, few studies have addressed the interactions between resting (nonactivated) NK cells and freshly isolated human tumors. Here, we show that human leukocyte antigen class Ilow tumor cells isolated directly from patients with advanced ovarian carcinoma trigger degranulation by resting allogeneic NK cells. This was paralleled by induction of granzyme B and caspase-6 activities in the tumor cells and significant tumor cell lysis. Ovarian carcinoma cells displayed ubiquitous expression of the DNAX accessory molecule-1 (DNAM-1) ligand PVR and sparse/heterogeneous expression of the NKG2D ligands MICA/MICB and ULBP1, ULBP2, and ULBP3. In line with the NK receptor ligand expression profiles, antibody-mediated blockade of activating receptor pathways revealed a dominant role for DNAM-1 and a complementary contribution of NKG2D signaling in tumor cell recognition. These results show that resting NK cells are capable of directly recognizing freshly isolated human tumor cells and identify ovarian carcinoma as a potential target for adoptive NK cell–based immunotherapy. [Cancer Res 2007;67(3):1317–25]
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, NKp30, NKp46, and DNAM-1 are NK activation receptors involved in the recognition and lysis of different tumors, such as hematological malignancies [82], melanoma [83], and ovarian cancer [84].”
From Immunosenescence: a key player in cancer development (2020) · cites this paper as [84]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J., Lanier, L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 3,272
Lanier, L. L. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,765
In search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687
Self-citationKiessling, R. W., Klein, E., & Wigzell, H. (1975) · European Journal of Immunology · doi:10.1002/eji.1830050208 · Cited by 1,900
Self-citationMiller, J. S., Soignier, Y., Panoskaltsis‐Mortari, A., McNearney, S. A., Yun, G. H., Fautsch, S. K., McKenna, D. H., Le, C. T., DeFor, T. E., Burns, L. J., et al. (2005) · Blood · doi:10.1182/blood-2004-07-2974 · Cited by 1,894
Betts, M. R., Brenchley, J. M., Price, D. A., Rosa, S. C. D., Douek, D. C., Roederer, M., & Koup, R. A. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(03)00265-5 · Cited by 1,596
CD107a as a functional marker for the identification of natural killer cell activity
Alter, G., Malenfant, J., & Altfeld, M. A. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.08.008 · Cited by 1,416
Cosman, D., Müllberg, J., Sutherland, C. L., Chin, W. A., Armitage, R., Fanslow, W., Kubin, M., & Chalupny, N. (2001) · Immunity · doi:10.1016/s1074-7613(01)00095-4 · Cited by 1,394
Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting Cells
Shlomchik, W. D., Couzens, M. S., Tang, C. B., McNiff, J. M., Robert, M. E., Liu, J., Shlomchik, M. J., & Emerson, S. G. (1999) · Science · doi:10.1126/science.285.5426.412 · Cited by 1,181
Cited by
Sorted by citations
Items 201–234 of 234
Checkpoint inhibition in the fight against cancer: NK cells have some to say in it
Sordo‐Bahamonde, C., Lorenzo‐Herrero, S., González, A. P., & Gonzalez, S. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824375-6.00013-8 · Cited by 1
Natural Killer Cells at the Tumors Microenvironment
Gazit, R., & Mandelboim, O. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6750-1_9 · Cited by 1
Kiessling, R. W. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-370454-2.00056-9 · Cited by 1
Self-citationNK Cell-Mediated Targeting of Human Ovarian Cancer and Possibilities for Immunotherapy
Silva, R. F., Alves, P. C. M., & Guimarães, F. (2011) · Annual Review of Biomedical Sciences
Natural Killer Cells in the Treatment of Human Cancer
Malmberg, K., & Ljunggren, H. (2009) · Springer eBooks · doi:10.1007/978-3-642-02309-5_22
Self-citationEngineering human pluripotent stem cells for enhanced lymphocyte development and function
Knorr, D. A. (2012) · University of Minnesota Digital Conservancy (University of Minnesota)
Natural killer cells in cancer : studies on migration and cytotoxicity
Wennerberg, E. (2014) · Figshare
Molecular specificities of NK cell-mediated recognition of human tumor cells
Carlsten, M. (2010) · Figshare
Self-citationTRIGGERING AND MECHANISMS OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY
Bryceson, Y. T. (2008) · Figshare
Self-citationMechanisms influencing natural killer cell recognition of tumour cells
Enqvist, M. (2016) · Figshare
Correia, D. V., Fogli, M., Hudspeth, K. L., da Silva, M. G., & Mavilio, D. (2011)
Close, H. J. (2016) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Immune modulation in serous epithelial ovarian cancer : focus on the role of tumor-derived exosomes
Labani-Motlagh, A. (2017)
Molfetta, R., Zitti, B., Santoni, A., & Paolini, R. (2017) · AIMS Allergy and Immunology · doi:10.3934/allergy.2017.4.164
Engineering NK Cells Towards Next Generation NK Cell Immunotherapy
Oei, V. Y. S. (2018) · NORA - Norwegian Open Research Archives
Mechanisms for immune escape in epithelial ovarian cancer
Israelsson, P. (2021) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Faculty Opinions recommendation of Targeting PVR (CD155) and its receptors in anti-tumor therapy.
Olive, D. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734144096.793574156
Natural killer cells in cancer
Höglund, P., & Ljunggren, H. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-370454-2.00004-1
Self-citationGuillamón, C. F., Martínez‐Sánchez, M. V., Gimeno, L., Mrowiec, A., Martínez-García, J., Server-Pastor, G., Martínez‐Escribano, J., Torroba, A., Ferri, B., Abellán, D., et al. (2023) · doi:10.1158/2326-6066.22540171.v1
Alsiary, R., Katouah, H. A., Al-Amodi, H. S. A. B., & Al-Toub, M. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815080384123010007
Clinical significance of serum CD155 levels in acute lymphoblastic leukemia patients
Ibrahim, N. M. I., Mostafa, M. A. O., Azzazi, M. O., Hegab, H. M. A.-A., Said, R. M. M., & Abdelfatah, R. G. (2023) · The Egyptian Journal of Haematology · doi:10.4103/ejh.ejh_50_23
Immunogénicite de la mort cellulaire induite par les chimiothérapies anti-cancéreuses
Aymeric, L. (2011) · theses.fr (ABES) · doi:10.70675/15e58e86z756bz4179z8fbbz6484931cb6da
Transcriptional Control of NK and iNKT Cell Development
Zhang, J. (2020) · theses.fr (ABES) · doi:10.70675/073dcbf5z7332z40c0zbba4z555a9ace31a5
Weulersse, M. (2019) · theses.fr (ABES) · doi:10.70675/2a56dbcazd721z44daz9b18z27d6c10e6137
Natural killer cells in ovarian cancer therapy: mechanisms, evasion, and therapeutic innovations
Long, W., Zhang, C., Zhang, C., Ni, J., Xiong, C., Wu, X., Li, M., Du, F., Chen, Y., Zhao, Y., et al. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02397-x
Metadata
- Authors
- Carlsten, M., Björkström, N. K., Norell, H., Bryceson, Y., van Hall, T., Baumann, B. C., Hanson, M., Schedvins, K., Kiessling, R., Ljunggren, H.-G., & Malmberg, K.-J.
- Affiliations
- Karolinska University Hospital (SE)
- 1Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge;
- 2Immune and Gene Therapy Laboratory, Cancer Center Karolinska, Department of Oncology and Pathology, Karolinska Institutet;
- Karolinska Institutet (SE)
- Venue
- Cancer Research
- Published
- 2007-02-01
- Volume
- 67
- Issue
- 3
- Pages
- 1317-1325
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2104794630
- Cited by
- 234
- References
- 40
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 8 · 2023: 10 · 2022: 7 · 2021: 14 · 2020: 18 · 2019: 11 · 2018: 16 · 2017: 14 · 2016: 11 · 2015: 14 · 2014: 14 · 2013: 14 · 2012: 14
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Novartis Foundation
- Stiftelsen för Strategisk Forskning
- Cancerfonden
- Svenska Sällskapet för Medicinsk Forskning
- Karolinska Institutet
- Vetenskapsrådet
- National Institutes of Health
- National Cancer Institute (R01CA102280, CA 102280)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Keywords
- DNAM-1, PVR, NKG2D, ovarian carcinoma, NK cell degranulation, granzyme B, caspase-6, ULBP, tumor cell lysis, NK cell therapy, cancer cell detection
- MeSH terms
- T Lineage-Specific Activation Antigen 1, Antigens, Differentiation, T-Lymphocyte, Female, Humans, Killer Cells, Natural, Ligands, Ovarian Neoplasms, Receptors, Immunologic, Cell Degranulation, K562 Cells, Granzymes, Receptors, Natural Killer Cell, NK Cell Lectin-Like Receptor Subfamily K
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
